The Role of Cost-Effectiveness Analysis in Managed-Care Decisions
- 1 January 1998
- journal article
- review article
- Published by Springer Nature in PharmacoEconomics
- Vol. 14 (Supplement) , 15-24
- https://doi.org/10.2165/00019053-199814001-00003
Abstract
This article considers the role of cost-effectiveness studies in the formulary and disease-state management decisions of managed-care entities. In a recently published symposium volume [Soc Sci Med...Keywords
This publication has 13 references indexed in Scilit:
- Pharmacy Benefit Management Companies (PBMs)PharmacoEconomics, 1998
- Introduction and overviewSocial Science & Medicine, 1997
- The Oregon experiment: The role of cost-benefit analysis in the allocation of Medicaid fundsSocial Science & Medicine, 1997
- Making economic evaluations respectableSocial Science & Medicine, 1997
- Cholesterol-reduction intervention study (CRIS): a randomized trial to assess effectiveness and costs in clinical practiceArchives of internal medicine (1960), 1996
- The FDA And Regulation Of Cost-Effectiveness ClaimsHealth Affairs, 1996
- The View From Managed Care PharmacyHealth Affairs, 1996
- MisoprostolPharmacoEconomics, 1993
- Economic Analysis Alongside Clinical Trials: Revisiting the Methodological IssuesInternational Journal of Technology Assessment in Health Care, 1991
- Cost Effectiveness of Vaccination against Pneumococcal PneumoniaNew England Journal of Medicine, 1980